Sep 08,2016
Spike Pharmaceuticals Enters Infant Drug Market
Kinderer Baby Pharmaceuticals Co., Ltd. Established
Spike Pharmaceuticals Enters Infant Drug Market
Recently, the Sino-German joint venture Zhejiang Jinder Baby Drug Co., Ltd., which is controlled by Jianfeng Pharmaceutical, has completed its registration. Jianfeng Pharmaceutical will introduce German technology and products on this basis to open up the infant drug market.
Zhejiang Jinderer Baby Drug Co., Ltd. was jointly funded by Jianfeng Pharmaceutical, Germany Gefu Pharmaceutical Co., Ltd. and Zhuhai Hengqin Deyunjia International Trade Co., Ltd., with a registered capital of 20 million yuan, of which Jianfeng Pharmaceutical contributed 11 million yuan in cash, accounting for 55% of the registered capital. Gefu Pharmaceuticals